Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? - Brosnan, Jeanette F; Sheppard, Brian L; Norris, Lucy A (Thrombosis and haemostasis, 2007)
Keywords: Administration, Cutaneous; Administration, Oral; Aged; alpha-2-Antiplasmin - metabolism; Antigens - blood; Antithrombins - metabolism; Blood Coagulation - drug effects; Cardiovascular Diseases - blood; Cardiovascular Diseases - chemically induced; Drug Combinations; Estradiol - administration & dosage; Estradiol - adverse effects; Estrogen Replacement Therapy - adverse effects; Factor VII; Female; Fibrinogen - metabolism; Fibrinolysin - metabolism; Fibrinolysis - drug effects; Humans; Ireland; Middle Aged; Norethindrone - administration & dosage; Norethindrone - adverse effects; Norethindrone - analogs & derivatives; Peptide Fragments - blood; Postmenopause; Prothrombin; Risk Factors; Time Factors; Tissue Plasminogen Activator - blood; Treatment Outcome; Ireland